These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7954842)

  • 1. Antibody production system modulated by oral administration of human milk and TGF-beta.
    Ishizaka S; Kimoto M; Tsujii T; Saito S
    Cell Immunol; 1994 Nov; 159(1):77-84. PubMed ID: 7954842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro.
    McKarns SC; Letterio JJ; Kaminski NE
    Int Immunopharmacol; 2003 Dec; 3(13-14):1761-74. PubMed ID: 14636827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral administration of a pectic polysaccharide fraction from a kampo (Japanese herbal) medicine "juzen-taiho-to" on antibody response of mice.
    Kiyohara H; Matsumoto T; Takemoto N; Kawamura H; Komatsu Y; Yamada H
    Planta Med; 1995 Oct; 61(5):429-34. PubMed ID: 7480204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-beta.
    Okamoto A; Kawamura T; Kanbe K; Kanamaru Y; Ogawa H; Okumura K; Nakao A
    Int Immunol; 2005 Jun; 17(6):705-12. PubMed ID: 15837712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milk-derived or recombinant transforming growth factor-beta has effects on immunological outcomes: a review of evidence from animal experimental studies.
    Oddy WH; McMahon RJ
    Clin Exp Allergy; 2011 Jun; 41(6):783-93. PubMed ID: 21492269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance.
    Ando T; Hatsushika K; Wako M; Ohba T; Koyama K; Ohnuma Y; Katoh R; Ogawa H; Okumura K; Luo J; Wyss-Coray T; Nakao A
    J Allergy Clin Immunol; 2007 Oct; 120(4):916-23. PubMed ID: 17606291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor.
    Santambrogio L; Hochwald GM; Saxena B; Leu CH; Martz JE; Carlino JA; Ruddle NH; Palladino MA; Gold LI; Thorbecke GJ
    J Immunol; 1993 Jul; 151(2):1116-27. PubMed ID: 8335893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis.
    Marth T; Strober W; Kelsall BL
    J Immunol; 1996 Sep; 157(6):2348-57. PubMed ID: 8805632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of liver-associated transforming growth factor beta 1 (TGF-beta 1) mRNA expression by carbon tetrachloride leads to the inhibition of T helper 2 cell-associated lymphokines.
    Jeon YJ; Han SH; Yang KH; Kaminski NE
    Toxicol Appl Pharmacol; 1997 May; 144(1):27-35. PubMed ID: 9169066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
    Chung Y; Lee SH; Kim DH; Kang CY
    J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma model.
    Dorigo O; Shawler DL; Royston I; Sobol RE; Berek JS; Fakhrai H
    Gynecol Oncol; 1998 Nov; 71(2):204-10. PubMed ID: 9826461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
    Strindelius L; Filler M; Sjöholm I
    Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin is an antagonist of TGF-beta activity and promotes proliferation of murine B cell hybridomas.
    Richards SM; Garman RD; Keyes L; Kavanagh B; McPherson JM
    Cell Immunol; 1998 Mar; 184(2):85-91. PubMed ID: 9630834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of CD8+ T cells by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1993 Jul; 151(2):668-77. PubMed ID: 8335902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells display natural suppressor activity partially by releasing transforming growth factor-beta.
    Hu ZQ; Yamazaki T; Cai Z; Yoshida T; Shimamura T
    Immunology; 1994 Jul; 82(3):482-6. PubMed ID: 7959885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
    Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C
    Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant activity of lactic bacteria: perspectives for its use in oral vaccines].
    Perdigón G; Alvarez S; Nader de Macías ME; Pesce de Ruiz Holgado AA
    Rev Argent Microbiol; 1988; 20(3):141-6. PubMed ID: 3231712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
    Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
    Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.